Muscle aging study for childhood cancer survivors
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study looks at muscle health and aging in adults who had childhood cancer. Researchers want to see how muscle mass and strength change over time and what factors (like past treatments) might affect this.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older and enrolled in the SJLIFE study.
- Have a low muscle mass score or low grip or leg strength.
- May or may not have been exposed to a nerve-damaging treatment.
- No metal implants or devices that would interfere with an MRI.
- Not be pregnant and weigh less than 300 pounds.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses imaging to look at how well the mitochondria (the tiny power plants inside your muscle cells) are working. It compares survivors of childhood leukemia who have low muscle mass to healthy volunteers, to understand muscle health and find ways to help.
This trial tests whether a structured exercise program can help breast cancer survivors who have low muscle mass and strength (sarcopenia). If you've finished your main treatments and are now in recovery, this study may help improve your muscle health.
This study looks at sarcopenia, which is age-related loss of muscle, in people with certain types of heart failure or in people with stable type 2 diabetes but no symptoms. The goal is to better understand muscle changes and what might help people stay stronger.
This study tests whether a personalized cooking, nutrition, and physical activity program can help reduce muscle loss in people with advanced cancer who are receiving chemotherapy.
This study looks at why cancer can cause loss of muscle in people with advanced non–small cell lung cancer, and whether exercise can improve or explain those muscle changes. You may be asked to do physical testing and answer questionnaires while receiving standard palliative cancer treatment.
This study looks at how loss of muscle strength or mass (sarcopenia) relates to advanced liver disease. It may help doctors understand which patients are at higher risk and could guide future care choices.
Hear when a new Muscle Weakness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.